within Pharmacolibrary.Drugs.ATC.R;

model R01AD04
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.8333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R01AD04</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Flunisolide is a synthetic corticosteroid used as an anti-inflammatory agent primarily in the management of asthma and allergic rhinitis. It is commonly administered via inhalation or intranasally. Flunisolide is approved for use in several countries for both adult and pediatric populations as a maintenance therapy in asthma and as a nasal spray for allergic rhinitis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult individuals after intranasal administration. No peer-reviewed publication could be identified to report detailed compartmental PK in humans; the parameters are based on product monographs and secondary reviews.</p><h4>References</h4><ol><li><p>Szefler, SJ (2001). Pharmacokinetics of intranasal corticosteroids. <i>The Journal of allergy and clinical immunology</i> 108(1 Suppl) S26–S31. DOI:<a href=\"https://doi.org/10.1067/mai.2001.115563\">10.1067/mai.2001.115563</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11449203/\">https://pubmed.ncbi.nlm.nih.gov/11449203</a></p></li><li><p>Kwaselow, A, et al., &amp; Chaplin, M (1985). A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect. <i>Allergy</i> 40(5) 363–367. DOI:<a href=\"https://doi.org/10.1111/j.1398-9995.1985.tb00248.x\">10.1111/j.1398-9995.1985.tb00248.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3898905/\">https://pubmed.ncbi.nlm.nih.gov/3898905</a></p></li><li><p>Bryson, HM, &amp; Faulds, D (1992). Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. <i>Drugs</i> 43(5) 760–775. DOI:<a href=\"https://doi.org/10.2165/00003495-199243050-00009\">10.2165/00003495-199243050-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1379151/\">https://pubmed.ncbi.nlm.nih.gov/1379151</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R01AD04;
